

[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
Sung Ji Nam Initiated (TWST) at Buy and Held Target at $33 on, Jan 5th, 2023
Sung Ji Nam of Scotiabank, Initiated "Twist Bioscience Corporation" (TWST) at Buy and Held Target at $33 on, Jan 5th, 2023.
Sung has made no other calls on TWST in the last 4 months.
There are 4 other peers that have a rating on TWST. Out of the 4 peers that are also analyzing TWST, 1 agrees with Sung's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Puneet Souda of "SVB Leerink" Maintained at Hold with Decreased Target to $30 on, Monday, November 21st, 2022
These are the ratings of the 3 analyists that currently disagree with Sung
- Vijay Kumar of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $36 on, Tuesday, January 3rd, 2023
- Catherine Schulte of "Baird" Maintained at Buy with Decreased Target to $33 on, Monday, November 21st, 2022
- Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $43 on, Monday, November 21st, 2022
Contributing Sources